| 产品描述: | IDO-IN-6 (NLG-1486) is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted from patent WO WO2012142237A1, Compound 1486, has an IC50 of <1 μM |
| 靶点: |
IDO:1 μM (IC50);IDO |
| 体外研究: |
IDO-IN-6 (Compound 1486) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC50 of <1 μM (this is the concentration of IDO-IN-6 at which inhibits 50% of enzymatic activity using recombinant human IDO) |
| 参考文献: |
1. Mautino, et al. Preparation of fused imidazole derivatives as IDO inhibitors. From PCT Int. Appl. (2012), 20121018. |
| 溶解性: |
soluble in DMSO |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.161 ml |
15.804 ml |
31.609 ml |
| 5 mM |
0.632 ml |
3.161 ml |
6.322 ml |
| 10 mM |
0.316 ml |
1.58 ml |
3.161 ml |
| 50 mM |
0.063 ml |
0.316 ml |
0.632 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |